Jess Hadley, community pharmacist and Professional Officer at PDL[/caption]
Peter Guthrey, Senior Pharmacist – Strategic Policy at PSA[/caption]
Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
Through crisis comes strength and reform
The COVID-19 pandemic continues to challenge us all every day. It challenges us to adjust to new ways of living. Crisis is often a catalyst for change.
I take Kakadu plum, is that ok?
How the new PSA guideline can help answer this question.
When asked about bush medicine most pharmacists would struggle. Bush medicine is a form of...
What is your 10 Year Vision?
Internationally, models of care delivered by pharmacists show significant impact in terms of better health outcomes, reduced costs to healthcare systems, and achieving full...
Pharmacists key to respiratory health in extreme weather
The recent dust storms and bushfires in NSW and Queensland serve as a reminder of the escalating effects of climate change, leading to an...
From the President: on the record
PSA is redoubling our efforts to ensure fair remuneration for pharmacists that reflects our training and expertise.
The launch of Pharmacists in 2023 in...
7CPA: An historic step forward
Last month, I was pleased to be the first PSA President to co-sign a Community Pharmacy Agreement (CPA) on behalf of the profession.
